{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:22:04Z","timestamp":1792174924095,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.drugalcdep.2020.108477","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T10:22:01Z","timestamp":1610101321000},"page":"108477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Willingness to initiate pre-exposure prophylaxis (PrEP) and its use among opioid-dependent individuals in drug treatment"],"prefix":"10.1016","volume":"219","author":[{"given":"Zhao","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick L.","family":"Altice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Wickersham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Copenhaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth E.","family":"DiDomizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LaRon E.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108477_bib0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2105\/AJPH.2019.305366","article-title":"Opioid use fueling HIV transmission in an urban setting: an outbreak of HIV infection among people who inject drugs-massachusetts, 2015-2018","volume":"110","author":"Alpren","year":"2020","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2020.108477_bib0010","series-title":"People Who Inject drugs-HIV and AIDS","author":"Avert","year":"2019"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108477_bib0015","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"Baeten","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108477_bib0020","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-018-0263-5","article-title":"Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs","volume":"15","author":"Biello","year":"2018","journal-title":"Harm Reduct. J."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108477_bib0025","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0277-9536(02)00403-3","article-title":"Sexual violence among a cohort of injection drug users","volume":"57","author":"Braitstein","year":"2003","journal-title":"Soc. Sci. Med."},{"issue":"16","key":"10.1016\/j.drugalcdep.2020.108477_bib0030","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","article-title":"The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test","volume":"158","author":"Bush","year":"1998","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2020.108477_bib0035","series-title":"Vulnerable Counties and Jurisdictions Experiencing or At-Risk of Outbreaks","author":"Centers for Disease Control and Prevention (CDC)","year":"2018"},{"key":"10.1016\/j.drugalcdep.2020.108477_bib0040","series-title":"HIV and People Who Inject Drugs","author":"Centers for Disease Control and Prevention (CDC)","year":"2020"},{"key":"10.1016\/j.drugalcdep.2020.108477_bib0045","series-title":"Persons Who Inject Drugs (PWID)","author":"Centers for Disease Control and Prevention (CDC)","year":"2020"},{"key":"10.1016\/j.drugalcdep.2020.108477_bib0050","series-title":"PrEP","author":"Centers for Disease Control and Prevention (CDC)","year":"2020"},{"issue":"9883","key":"10.1016\/j.drugalcdep.2020.108477_bib0055","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2020.108477_bib0060","series-title":"CT Pre-exposure Prophylaxis (PrEP) Local Medical Services","author":"Connecticut Department of Public Health","year":"2019"},{"key":"10.1016\/j.drugalcdep.2020.108477_bib0065","series-title":"HIV Surveillance","author":"Health CSDoP","year":"2020"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108477_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028238","article-title":"Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study","volume":"7","author":"Eisingerich","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108477_bib0075","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1258\/ijsa.2009.009255","article-title":"Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations","volume":"22","author":"Galea","year":"2011","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.drugalcdep.2020.108477_bib0080","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.healthplace.2014.04.008","article-title":"Accessibility and utilization patterns of a mobile medical clinic among vulnerable populations","volume":"28","author":"Gibson","year":"2014","journal-title":"Health Place"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108477_bib0085","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1089\/apc.2012.0419","article-title":"From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City","volume":"27","author":"Golub","year":"2013","journal-title":"AIDS Patient Care STDS"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108477_bib0090","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/add.13437","article-title":"\u2019PrEP is not ready for our community, and our community is not ready for PrEP\u2019: pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response","volume":"112","author":"Guise","year":"2017","journal-title":"Addiction"},{"issue":"16","key":"10.1016\/j.drugalcdep.2020.108477_bib0095","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1097\/QAD.0000000000001627","article-title":"Pre-exposure prophylaxis for MSM and transgender persons in early adopting countries","volume":"31","author":"Hoornenborg","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2020.108477_bib0100","series-title":"The Pre-exposure Prophylaxis (PrEP) Care Cascade in People Who Inject Drugs: A Systematic Review","author":"Mistler","year":"2020"},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.108477_bib0105","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s10461-012-0359-y","article-title":"Perceived likelihood of using HIV pre-exposure prophylaxis medications among young men who have sex with men","volume":"17","author":"Mustanski","year":"2013","journal-title":"AIDS Behav."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108477_bib0110","doi-asserted-by":"crossref","DOI":"10.7448\/IAS.20.1.21234","article-title":"Feasibility and acceptability of HIV self-testing among pre-exposure prophylaxis users in Kenya","volume":"20","author":"Ngure","year":"2017","journal-title":"J. Int. AIDS Soc."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108477_bib0115","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s12879-018-3415-z","article-title":"Acceptability of HIV self-testing to support pre-exposure prophylaxis among female sex workers in Uganda and Zambia: results from two randomized controlled trials","volume":"18","author":"Ortblad","year":"2018","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108477_bib0120","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s13063-019-3521-2","article-title":"HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya","volume":"20","author":"Ortblad","year":"2019","journal-title":"Trials"},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108477_bib0125","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D scale: a self-report depression scale for research in the general population","volume":"1","author":"Radloff","year":"1977","journal-title":"Appl. Psychol. Meas."},{"issue":"5152","key":"10.1016\/j.drugalcdep.2020.108477_bib0130","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","article-title":"Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017","volume":"67","author":"Scholl","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2020.108477_bib0135","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drugalcdep.2018.08.014","article-title":"PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland","volume":"195","author":"Sherman","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108477_bib0140","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2018.00195","article-title":"Exploring the use of pre-exposure prophylaxis (PrEP) for HIV prevention among high-risk people who use drugs in treatment","volume":"6","author":"Shrestha","year":"2018","journal-title":"Front. Public Health"},{"key":"10.1016\/j.drugalcdep.2020.108477_bib0145","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.12.023","article-title":"Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment","volume":"173","author":"Shrestha","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108477_bib0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00561","article-title":"Developing an integrated, brief biobehavioral HIV prevention intervention for high-risk drug users in treatment: the process and outcome of formative research","volume":"8","author":"Shrestha","year":"2017","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108477_bib0155","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1007\/s10461-017-1851-1","article-title":"Measuring acceptability and preferences for implementation of pre-exposure prophylaxis (PrEP) using conjoint analysis: an application to primary HIV prevention among high risk drug users","volume":"22","author":"Shrestha","year":"2018","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2020.108477_bib0160","doi-asserted-by":"crossref","first-page":"108058","DOI":"10.1016\/j.jsat.2020.108058","article-title":"Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs","volume":"117","author":"Shrestha","year":"2020","journal-title":"J. Subst. Abuse Treat."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108477_bib0165","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-018-3472-3","article-title":"HIV prevalence, related risk behaviors, and correlates of HIV infection among people who use drugs in Cambodia","volume":"18","author":"Sopheab","year":"2018","journal-title":"BMC Infect. Dis."},{"issue":"9","key":"10.1016\/j.drugalcdep.2020.108477_bib0170","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1007\/s10461-014-0778-z","article-title":"Willingness to use HIV pre-exposure prophylaxis among opiate users","volume":"18","author":"Stein","year":"2014","journal-title":"AIDS Behav."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108477_bib0175","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/ADM.0b013e31827f9bdf","article-title":"Association between risk behaviors and antiretroviral resistance in HIV-infected patients receiving opioid agonist treatment","volume":"7","author":"Tetrault","year":"2013","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2020.108477_bib0180","series-title":"A Comprehensive Report on Ending the HIV Epidemic in Connecticut","author":"The Connecticut Getting to Zero Commission","year":"2018"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108477_bib0185","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana","volume":"367","author":"Thigpen","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2020.108477_bib0190","series-title":"5 Years After Indiana\u2019s Historic HIV Outbreak, Many Rural Places Remain At Risk","author":"Ungar","year":"2020"},{"key":"10.1016\/j.drugalcdep.2020.108477_bib0195","series-title":"Rural Indiana Struggles With Drug-Fueled HIV Epidemic","author":"Varney","year":"2015"},{"issue":"1 Suppl 2","key":"10.1016\/j.drugalcdep.2020.108477_bib0200","doi-asserted-by":"crossref","first-page":"S167","DOI":"10.1016\/j.amepre.2012.10.006","article-title":"From efficacy to impact: an advocate\u2019s agenda for HIV pre-exposure prophylaxis implementation","volume":"44","author":"Warren","year":"2013","journal-title":"Am. J. Prev. Med."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108477_bib0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054288","article-title":"Are Thai MSM willing to take PrEP for HIV prevention? An analysis of attitudes, preferences and acceptance","volume":"8","author":"Wheelock","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108477_bib0210","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-017-0141-6","article-title":"Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study","volume":"14","author":"Wiessing","year":"2017","journal-title":"Harm Reduct. J."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108477_bib0215","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11524-018-0238-6","article-title":"Correlates of sexual coercion among people who inject drugs (PWID) in Los Angeles and San Francisco, CA","volume":"96","author":"Williams","year":"2019","journal-title":"J. Urban Health"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108477_bib0220","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30101-9","article-title":"Pre-exposure prophylaxis (PrEP) for MSM in low HIV incidence places: should high risk individuals be targeted?","volume":"8","author":"Wong","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.drugalcdep.2020.108477_bib0225","series-title":"World Health Organization Guidelines on HIV Self-testing and Partner Notification: Supplement to Consolidated Guidelines on HIV Testing Services","author":"World Health Organization","year":"2016"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620306426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620306426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T22:28:54Z","timestamp":1732314534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871620306426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":45,"alternative-id":["S0376871620306426"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108477","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Willingness to initiate pre-exposure prophylaxis (PrEP) and its use among opioid-dependent individuals in drug treatment","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108477","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108477"}}